CoChat

Pharmacological AMP Kinase Activators Target the Nucleolar Organization and Control Cell Proliferation

Open access

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Abstract

AIMS: Phenformin, resveratrol and AICAR stimulate the energy sensor 5'-AMP activated kinase (AMPK) and inhibit the first step of ribosome biogenesis, de novo RNA synthesis in nucleoli. Nucleolar activities are relevant to human health, because ribosome production is crucial to the development of diabetic complications. Although the function of nucleoli relies on their organization, the impact of AMPK activators on nucleolar structures is not known. Here, we addressed this question by examining four nucleolar proteins that are essential for ribosome biogenesis. METHODS: Kidney cells were selected as model system, because diabetic nephropathy is one of the complications associated with diabetes mellitus. To determine the impact of pharmacological agents on nucleoli, we focused on the subcellular and subnuclear distribution of B23/nucleophosmin, fibrillarin, nucleolin and RPA194. This was achieved by quantitative confocal microscopy at the single-cell level in combination with cell fractionation and quantitative Western blotting. RESULTS: AMPK activators induced the re-organization of nucleoli, which was accompanied by changes in cell proliferation. Among the compounds tested, phenformin and resveratrol had the most pronounced impact on nucleolar organization. For B23, fibrillarin, nucleolin and RPA194, both agents (i) altered the nucleocytoplasmic distribution and nucleolar association and (ii) reduced significantly the retention in the nucleus. (iii) Phenformin and resveratrol also increased significantly the total concentration of B23 and nucleolin. CONCLUSIONS: AMPK activators have unique effects on the subcellular localization, nuclear retention and abundance of nucleolar proteins. We propose that the combination of these events inhibits de novo ribosomal RNA synthesis and modulates cell proliferation. Our studies identified nucleolin as a target that is especially sensitive to pharmacological AMPK activators. Because of its response to pharmacological agents, nucleolin represents a potential biomarker for the development of drugs that diminish diabetic renal hypertrophy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0088087

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The pharmacological compounds phenformin, resveratrol and AICAR alter the compartment-specific concentration and subcellular distribution of the nucleolar protein B23. B23 was detected by indirect immunolocalization in controls treated with vehicle (DMSO, D; water, W), phenformin (Phen, Ph), resveratrol (Res) or AICAR (AIC). Confocal images were acquired and fluorescence intensities were quantified for subcellular compartments. (A) Antibody staining is shown for B23, nuclei were identified with DAPI (4′,6-diamidino-2-phenylindole). Size bar is 20 µm. Graphs depict the changes in nuclear (Nuc), cytoplasmic (Cyt) and nucleolar (No) compartments. Data are shown as pixel intensities/area+SEM. Fluorescence intensities for controls (DMSO, Water) were defined as 1. Furthermore, the nuclear/cytoplasmic, nucleolar/nuclear and nucleolar/cytoplasmic ratio was calculated for each treatment. (B) Single cell analyses were performed to evaluate changes in the nuclear/cytoplasmic and nucleolar/nuclear distribution of B23. Trendlines were added and results for linear regression are shown.
Figure 1 The pharmacological compounds phenformin, resveratrol and AICAR alter the compartment-specific concentration and subcellular distribution of the nucleolar protein B23. B23 was detected by indirect immunolocalization in controls treated with vehicle (DMSO, D; water, W), phenformin (Phen, Ph), resveratrol (Res) or AICAR (AIC). Confocal images were acquired and fluorescence intensities were quantified for subcellular compartments. (A) Antibody staining is shown for B23, nuclei were identified with DAPI (4′,6-diamidino-2-phenylindole). Size bar is 20 µm. Graphs depict the changes in nuclear (Nuc), cytoplasmic (Cyt) and nucleolar (No) compartments. Data are shown as pixel intensities/area+SEM. Fluorescence intensities for controls (DMSO, Water) were defined as 1. Furthermore, the nuclear/cytoplasmic, nucleolar/nuclear and nucleolar/cytoplasmic ratio was calculated for each treatment. (B) Single cell analyses were performed to evaluate changes in the nuclear/cytoplasmic and nucleolar/nuclear distribution of B23. Trendlines were added and results for linear regression are shown.CC BY · PubMed Central
Figure 2 Impact of phenformin, resveratrol and AICAR on fibrillarin. Experiments were performed and data analyzed as described in detail for Fig. 1.
Figure 2 Impact of phenformin, resveratrol and AICAR on fibrillarin. Experiments were performed and data analyzed as described in detail for Fig. 1.CC BY · PubMed Central
Figure 3 Phenformin, resveratrol and AICAR target nucleolin. Experimental design and data analysis followed the methods depicted for Fig. 1.
Figure 3 Phenformin, resveratrol and AICAR target nucleolin. Experimental design and data analysis followed the methods depicted for Fig. 1.CC BY · PubMed Central
Figure 4 RPA194 subcellular abundance and distribution are modulated by phenformin, resveratrol and AICAR. A detailed description of the experimental set-up and data analyses is provided for Fig. 1.
Figure 4 RPA194 subcellular abundance and distribution are modulated by phenformin, resveratrol and AICAR. A detailed description of the experimental set-up and data analyses is provided for Fig. 1.CC BY · PubMed Central
Figure 5 Pharmacological AMPK activators control the association of B23, fibrillarin, nucleolin and RPA194 with the nucleus. Kidney cells were incubated with vehicle (DMSO, D; Water, W), phenformin (Phen Ph), resveratrol (Res) or AICAR (AIC). Quantitative Western blotting was performed for nuclear and cytoplasmic fractions. (A) Blots were probed with antibodies against nucleolar proteins B23, fibrillarin, nucleolin or RPA194 and ECL signals were measured. The nuclear/cytoplasmic ratio was calculated; this ratio was defined as 1 for control samples. Bar graphs depict results as average+SEM for at least three independent experiments for each data point. *p<0.05; **p<0.01. (B) Control experiments evaluated the distribution of the cytoplasmic marker protein lactate dehydrogenase (LDH) and the nuclear protein lamin A.
Figure 5 Pharmacological AMPK activators control the association of B23, fibrillarin, nucleolin and RPA194 with the nucleus. Kidney cells were incubated with vehicle (DMSO, D; Water, W), phenformin (Phen Ph), resveratrol (Res) or AICAR (AIC). Quantitative Western blotting was performed for nuclear and cytoplasmic fractions. (A) Blots were probed with antibodies against nucleolar proteins B23, fibrillarin, nucleolin or RPA194 and ECL signals were measured. The nuclear/cytoplasmic ratio was calculated; this ratio was defined as 1 for control samples. Bar graphs depict results as average+SEM for at least three independent experiments for each data point. *p<0.05; **p<0.01. (B) Control experiments evaluated the distribution of the cytoplasmic marker protein lactate dehydrogenase (LDH) and the nuclear protein lamin A.CC BY · PubMed Central
Figure 6 Effect of phenformin, resveratrol and AICAR on the abundance of nucleolar proteins and histone H3 phosphorylation. (A) Kidney cells were treated with vehicle or the pharmacological compound indicated. Crude extracts were probed with antibodies against B23, fibrillarin, nucleolin or RPA194; actin provided a loading control. The abundance was calculated as nucleolar protein/actin for at least three independent experiments; results were defined as 1 for control samples. Data are shown as averages+SEM; significant differences are marked with *p<0.05 or **p<0.01. (B) Signals for phospho(Ser10)-histone H3 (p-H3) were measured for crude cell extracts as described for part A.
Figure 6 Effect of phenformin, resveratrol and AICAR on the abundance of nucleolar proteins and histone H3 phosphorylation. (A) Kidney cells were treated with vehicle or the pharmacological compound indicated. Crude extracts were probed with antibodies against B23, fibrillarin, nucleolin or RPA194; actin provided a loading control. The abundance was calculated as nucleolar protein/actin for at least three independent experiments; results were defined as 1 for control samples. Data are shown as averages+SEM; significant differences are marked with *p<0.05 or **p<0.01. (B) Signals for phospho(Ser10)-histone H3 (p-H3) were measured for crude cell extracts as described for part A.CC BY · PubMed Central
Figure 7 Nuclear de novo DNA synthesis is diminished by AMPK activators. Newly synthesized DNA was measured during the incubation with phenformin, resveratrol or AICAR. To detect DNA synthesis, EdU was added together with the pharmacological compound or vehicle. Following a 1-h incubation, cells were fixed and EdU labeled with Alexa Fluor555. Microscopic images were acquired for all samples, and nuclear pixel intensities/area were determined for at least 130 cells for each experiment and every condition. Size bar is 20 µm. Significant differences were identified with student’s ttest; **p<0.01; *p<0.05.
Figure 7 Nuclear de novo DNA synthesis is diminished by AMPK activators. Newly synthesized DNA was measured during the incubation with phenformin, resveratrol or AICAR. To detect DNA synthesis, EdU was added together with the pharmacological compound or vehicle. Following a 1-h incubation, cells were fixed and EdU labeled with Alexa Fluor555. Microscopic images were acquired for all samples, and nuclear pixel intensities/area were determined for at least 130 cells for each experiment and every condition. Size bar is 20 µm. Significant differences were identified with student’s ttest; **p<0.01; *p<0.05.CC BY · PubMed Central
Figure 8 Effect of AMPK activators on lamin A and PARP1 cleavage. After 1-h treatment with vehicle (D, DMSO; W, water), phenformin, resveratrol or AICAR, kidney cells were incubated with fresh medium for 24 h. In parallel, apoptosis was induced with staurosporine (STS); the vehicle DMSO served as negative control. At the end of the 24-h incubation period, attached and floating cells were combined for each sample, and crude extracts were probed with antibodies against lamin A, PARP1 or actin. Cleavage of lamin A and PARP1, which is associated with apoptosis, occured in staurosporine-treated cells, but not in response to phenformin, resveratrol or AICAR.
Figure 8 Effect of AMPK activators on lamin A and PARP1 cleavage. After 1-h treatment with vehicle (D, DMSO; W, water), phenformin, resveratrol or AICAR, kidney cells were incubated with fresh medium for 24 h. In parallel, apoptosis was induced with staurosporine (STS); the vehicle DMSO served as negative control. At the end of the 24-h incubation period, attached and floating cells were combined for each sample, and crude extracts were probed with antibodies against lamin A, PARP1 or actin. Cleavage of lamin A and PARP1, which is associated with apoptosis, occured in staurosporine-treated cells, but not in response to phenformin, resveratrol or AICAR.CC BY · PubMed Central
Figure 9 Impact of AMPK activators on nuclear integrity. Kidney cells were treated as described in Fig. 8. At th end of the 24-h incubation, cells attached to the growth support were stained with antibodies against lamin A and nuclei detected with DAPI. Fragmented nuclei are marked with arrows. Size bar is 20 µm.
Figure 9 Impact of AMPK activators on nuclear integrity. Kidney cells were treated as described in Fig. 8. At th end of the 24-h incubation, cells attached to the growth support were stained with antibodies against lamin A and nuclei detected with DAPI. Fragmented nuclei are marked with arrows. Size bar is 20 µm.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 65 references

Research works printed but not linked: 2

  1. Y Ahmad, 2009, NOPdb: Nucleolar Proteome Database–2008 update, Nucleic Acid Res, 37, D181, 10.1093/nar/gkn804 · DOI · Paper page
  2. H Mahboubi, 2013, Methods developed for the automated quantitative analysis of granular compartments reveal novel attributes of stress granule organization, Microsc Microanal, 19, 617

Cited by

See all 29

Metadata

Authors
Kodiha, M., Salimi, A., Wang, Y. M., & Stochaj, U.
Affiliations
McGill University (CA)
Corresponding author
Stochaj, Ursula
Venue
PLoS ONE
Published
2014-01-30
Volume
9
Issue
1
Pages
e88087
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2093844741
Cited by
29
References
65
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2021: 9 · 2020: 1 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 2 · 2014: 2
FWCI
1.09
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Heart and Stroke Foundation of Canada
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
Keywords
AMPK, AMPK activators, nucleolar organization, ribosome biogenesis, nucleolin, fibrillarin, phenformin, resveratrol, AICAR, cell proliferation, diabetic nephropathy, subcellular localization, nucleocytoplasmic distribution, ribosomal RNA synthesis
MeSH terms
Resveratrol, Nucleophosmin, Nucleolin, Aminoimidazole Carboxamide, Cell Line, Cell Nucleolus, Chromosomal Proteins, Non-Histone, Humans, Nuclear Proteins, Nucleolus Organizer Region, Phenformin, Phosphoproteins, Ribonucleotides, Ribosomes, Stilbenes, RNA-Binding Proteins, Cell Proliferation, AMP-Activated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacological AMP Kinase Activators Target the Nucleolar Organization and Control Cell Proliferation. https://app.cochat.ai/papers/10.1371/journal.pone.0088087
The paper
Kodiha, M., Salimi, A., Wang, Y. M., & Stochaj, U. (2014). Pharmacological AMP Kinase Activators Target the Nucleolar Organization and Control Cell Proliferation. PLoS ONE. https://doi.org/10.1371/journal.pone.0088087

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.